Viewing Study NCT00272012


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2026-01-31 @ 4:28 AM
Study NCT ID: NCT00272012
Status: COMPLETED
Last Update Posted: 2009-12-07
First Post: 2006-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OPAL - Insulin Glulisine, Diabetes Mellitus
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 View
Keywords: